Flora Growth Corp (FLGC)
0.9108
-0.01
(-1.00%)
USD |
NASDAQ |
Jul 08, 16:00
0.9108
0.00 (0.00%)
After-Hours: 20:00
Flora Growth SG&A Expense (TTM): 21.51M for March 31, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 21.51M |
December 31, 2023 | 23.34M |
September 30, 2023 | 24.55M |
June 30, 2023 | 27.13M |
March 31, 2023 | 27.57M |
December 31, 2022 | 30.17M |
Date | Value |
---|---|
September 30, 2022 | 31.51M |
June 30, 2022 | 28.24M |
March 31, 2022 | 24.04M |
December 31, 2021 | 16.69M |
September 30, 2021 | 10.24M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
10.24M
Minimum
Sep 2021
31.51M
Maximum
Sep 2022
24.09M
Average
24.55M
Median
Sep 2023
SG&A Expense (TTM) Benchmarks
Palatin Technologies Inc | 13.34M |
Oragenics Inc | 5.999M |
PTC Therapeutics Inc | 318.90M |
GT Biopharma Inc | 7.409M |
Corvus Pharmaceuticals Inc | 7.079M |